Computational Toxicology – Risk Assessment for Chemicals: Wiley Series on Technologies for the Pharmaceutical Industry
Autor S Ekinsen Limba Engleză Hardback – 10 apr 2018
- Provides a perspective of what is currently achievable with computational toxicology and a view to future developments
- Helps readers overcome questions of data sources, curation, treatment, and how to model / interpret critical endpoints that support 21st century hazard assessment
- Assembles cutting-edge concepts and leading authors into a unique and powerful single-source reference
- Includes in-depth looks at QSAR models, physicochemical drug properties, structure-based drug targeting, chemical mixture assessments, and environmental modeling
- Features coverage about consumer product safety assessment and chemical defense along with chapters on open source toxicology and big data
Preț: 833.75 lei
Preț vechi: 1239.38 lei
-33% Nou
Puncte Express: 1251
Preț estimativ în valută:
159.56€ • 167.81$ • 132.91£
159.56€ • 167.81$ • 132.91£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781119282563
ISBN-10: 111928256X
Pagini: 432
Dimensiuni: 154 x 233 x 26 mm
Greutate: 0.64 kg
Ediția:2nd Edition
Editura: Wiley
Seria Wiley Series on Technologies for the Pharmaceutical Industry
Locul publicării:Hoboken, United States
ISBN-10: 111928256X
Pagini: 432
Dimensiuni: 154 x 233 x 26 mm
Greutate: 0.64 kg
Ediția:2nd Edition
Editura: Wiley
Seria Wiley Series on Technologies for the Pharmaceutical Industry
Locul publicării:Hoboken, United States
Public țintă
Toxicologists, chemists, ADME/Tox and pharmaceutical scientists, computational chemists, drug discovery scientistsPharmaceutical scientists interested in drug safety evaluation, drug design, and metabolism like directors of investigative toxicology and ADME and PK personnel
Environmental toxicologists and risk assessment personnel
Academic and research scientists in toxicology, drug development, chemical and biological modelling
Regulatory like the NIH, ATSDR, and EPA
Cuprins
Notă biografică
Sean Ekins, MSc, PhD, DSc has over 20 years of pharmaceutical and toxicology experience. He is the founder or co-founder of two companies and Adjunct Professor at three universities. He has been awarded 16 NIH grants as Principal Investigator. He has authored or co authored over 285 peer-reviewed papers and book chapters and edited five books with Wiley. His research is focused on collaborations to facilitate rare and neglected disease drug discovery.